• Abe, M., Hiura, K., Wilde, J., Moriyama, K., Hashimoto, T., Ozaki, S., Wakatsuki, S., Kosaka, M., Kido, S., Inoue, D. & Matsumoto, T. (2002) Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma. Blood, 100, 21952202.
  • Abildgaard, N., Brixen, K., Kristensen, J.E., Eriksen, E.F., Nielsen, J.L. & Heickendorff, L. (2003) Comparison of five biochemical markers of bone resorption in multiple myeloma: elevated pre-treatment levels of S-ICTP and U-Ntx are predictive for early progression of the bone disease during standard chemotherapy. British Journal of Haematology, 120, 235242.
  • Choi, S.J., Cruz, J.C., Craig, F., Chung, H., Devlin, R.D., Roodman, G.D. & Alsina, M. (2000) Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma. Blood, 96, 671675.
  • Choi, S.J., Oba, Y., Gazitt, Y., Alsina, M., Cruz, J., Anderson, J. & Roodman, G.D. (2001) Antisense inhibition of macrophage inflammatory protein 1-alpha blocks bone destruction in a model of myeloma bone disease. Journal of Clinical Investigation, 108, 18331841.
  • Han, J.H., Choi, S.J., Kurihara, N., Koide, M., Oba, Y. & Roodman, G.D. (2001) Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappa B ligand. Blood, 97, 33493353.
  • Lentzsch, S., Gries, M., Janz, M., Bargou, R., Dorken, B. & Mapara, M.Y. (2003) Macrophage inflammatory protein-1alpha (MIP-1{alpha}) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells. Blood, 101, 35683573.
  • Oyajobi, B.O. & Mundy, G.R. (2003) Receptor activator of NF-kappaB ligand, macrophage inflammatory protein-1alpha, and the proteasome. Cancer, 97, 813817.
  • Terpos, E., De La Fuente, J., Szydlo, R., Hatjiharissi, E., Viniou, N., Meletis, J., Yataganas, X., Goldman, J.M. & Rahemtulla, A. (2003) Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma. International Journal of Cancer, 106, 455457.
  • Uneda, S., Hata, H., Matsuno, F., Harada, N., Mitsuya, Y., Kawano, F. & Mitsuya, H. (2003) Macrophage inflammatory protein-1 alpha is produced by human multiple myeloma (MM) cells and its expression correlates with bone lesions in patients with MM. British Journal of Haematology, 120, 5355.